Search results
Showing 1 to 5 of 5 results for indapamide
Targeted-release budesonide for treating primary IgA nephropathy (review of TA937) [ID6485]
In development Reference number: GID-TA11662 Expected publication date: 25 February 2026
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]
In development Reference number: GID-TA11454 Expected publication date: 23 July 2026
example, amlodipine, felodipine and lacidipine). A common example is indapamide. Table 2. What medicines could I try to control my blood...
Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034
Topic prioritisation
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.